VEGFA and glioblastoma: Furthermore, PlGF has been shown to enhance VEGF signaling activity and mediate angiogenic escape [37], as Batchelor et al. found, levels of P1GF were increased in recurrent glioblastoma patients following treatment with cediranib monotherapy, a VEGFR tyrosine kinase inhibitor [38].